Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD34 Selected Peripheral Blood Stem Cell Graft”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Not applicableStudy completedNCT02909075
What this trial is testing

Assess Thymic Function Using PET/CT and MRI

Who this might be right for
CD34 Selected Peripheral Blood Stem Cell Graft
Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Study completedNCT00010335
What this trial is testing

Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

Who this might be right for
Systemic SclerosisSystemic Lupus ErythematosusDermatomyositis+2 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)Study completedNCT00368355
What this trial is testing

T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts

Who this might be right for
Acute Lymphoblastic LeukemiaNon Hodgkins LymphomaMyelodysplastic Syndrome+6 more
Baylor College of Medicine 46
Not applicableLooking for participantsNCT02438904
What this trial is testing

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00993486
What this trial is testing

Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Hematologic DiseasesHematologic Malignancies
Kiadis Pharma 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT01966367
What this trial is testing

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

Who this might be right for
Bone Marrow Failure SyndromeSevere Aplastic AnemiaSevere Congenital Neutropenia+13 more
Diane George 37
Early research (Phase 1)Study completedNCT00002788
What this trial is testing

High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 15
Not applicableNo Longer AvailableNCT01200017
What this trial is testing

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+9 more
Christopher Dvorak
Testing effectiveness (Phase 2)Study completedNCT00004900
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hackensack Meridian Health
Large-scale testing (Phase 3)Ended earlyNCT00967343
What this trial is testing

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Myeloid LeukemiaLymphoblastic LeukemiaLymphoma+3 more
Kiadis Pharma 40
Not applicableAvailableNCT06731036
What this trial is testing

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Who this might be right for
Severe Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more
University of Florida
Large-scale testing (Phase 3)Ended earlyNCT00003056
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaGraft Versus Host Disease
Baxalta now part of Shire 105
Early research (Phase 1)Study completedNCT00376480
What this trial is testing

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT00004906
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hackensack Meridian Health
Early research (Phase 1)Study completedNCT00007813
What this trial is testing

Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Testing effectiveness (Phase 2)Study completedNCT01517035
What this trial is testing

Improving Blood Stem Cell Collection and Transplant Procedures

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 43
Testing effectiveness (Phase 2)Study completedNCT00186680
What this trial is testing

CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant

Who this might be right for
Breast Cancer
Stanford University 99
Testing effectiveness (Phase 2)Study completedNCT00002718
What this trial is testing

T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center 31